Tag Archives: Nexium

EPO revokes Esomeprazole patent

[WSJ] [Bloomberg] [Pharmaletter] EPO last Friday revokes EP1020461, which covers magnesium salt of Esomeprazole and it is divisional patent of EP0652872 (product patent). ‘461 patent revocation status not yet updated in European patent register. ‘461 patent was opposed by many companies including Teva, Hexal, Lupin etc. … Continue reading

Posted in Patent case | Tagged , , | 1 Comment